title: Mechanism of inhibition of the GluA2 AMPA receptor channel opening by talampanel and its enantiomer: the stereochemistry of the 4-methyl group on the diazepine ring of 2,3-benzodiazepine derivatives.
abstract: Stereoselectivity of 2,3-benzodiazepine compounds provides a unique way for the design of stereoisomers as more selective and more potent inhibitors as drug candidates for treatment of the neurological diseases involving excessive activity of AMPA receptors. Here we investigate a pair of enantiomers known as Talampanel and its (+) counterpart about their mechanism of inhibition and selectivity toward four AMPA receptor subunits or GluA1-4. We show that Talampanel is the eutomer with the endismic ratio being 14 for the closed-channel and 10 for the open-channel state of GluA2. Kinetic evidence supports that Talampanel is a noncompetitive inhibitor and it binds to the same site for those 2,3-benzodiazepine compounds with the C-4 methyl group on the diazepine ring. This site, which we term as the "M" site, recognizes preferentially those 2,3-benzodiazepine compounds with the C-4 methyl group being in the R configuration, as in the chemical structure of Talampanel. Given that Talampanel inhibits GluA1 and GluA2, but is virtually ineffective on the GluA3 and GluA4 AMPA receptor subunits, we hypothesize that the "M" site(s) on GluA1 and GluA2 to which Talampanel binds is different from that on GluA3 and GluA4. If the molecular properties of the AMPA receptors and Talampanel are used for selecting an inhibitor as a single drug candidate for controlling the activity of all AMPA receptors in vivo, Talampanel is not ideal. Our results further suggest that addition of longer acyl groups to the N-3 position should produce more potent 2,3-benzodiazepine inhibitors for the "M" site.
authors: Department of Chemistry and Center for Neuroscience Research, University at Albany, SUNY, Albany, NY 12222, USA.
authors: Congzhou
authors: C
authors: Wang
authors: Li
authors: L
authors: Niu
mesh_terms: D001569:Benzodiazepines / Q000737:chemistry* / Q000378:metabolism*; D057809:HEK293 Cells; D006801:Humans; D018091:Receptors, AMPA / Q000037:antagonists & inhibitors* / Q000378:metabolism*; D013237:Stereoisomerism; D013329:Structure-Activity Relationship
chemical_list: D018091:Receptors, AMPA; D001569:Benzodiazepines; C085266:talampanel; C104722:glutamate receptor ionotropic, AMPA 2
references: Prog Brain Res. 1998;116:371-83
references: 9932389
references: Chirality. 2007 Sep;19(9):658-82
references: 17390370
references: Biochemistry. 2012 Feb 28;51(8):1787-95
references: 22304561
references: Eur J Pharmacol. 1989 Aug 22;167(2):193-9
references: 2574112
references: Brain Res Bull. 2005 Jul 15;66(1):43-9
references: 15925143
references: Neurotherapeutics. 2007 Jan;4(1):126-9
references: 17199027
references: Protein Sci. 2002 Jun;11(6):1330-9
references: 12021432
references: Biochemistry. 2009 May 5;48(17):3767-77
references: 19275243
references: J Neurochem. 2006 Aug;98(3):782-91
references: 16893420
references: Biochemistry. 2012 Jan 24;51(3):761-8
references: 22191429
references: J Neurosci Res. 2004 Aug 15;77(4):573-82
references: 15264227
references: Biochim Biophys Acta. 2006 Nov-Dec;1762(11-12):1068-82
references: 16806844
references: J Pharmacol Exp Ther. 1994 Oct;271(1):25-9
references: 7525924
references: Epilepsia. 2009 Apr;50(4):694-701
references: 19220413
references: Amyotroph Lateral Scler. 2010 May 3;11(3):266-71
references: 19961264
references: Nat Med. 2002 Sep;8(9):971-8
references: 12172541
references: Neurosci Lett. 1999 Mar 12;262(3):219-21
references: 10218895
references: Br J Pharmacol. 1980 Apr;68(4):711-7
references: 7378644
references: ACS Chem Neurosci. 2011 May 12;2(9):506-513
references: 22059113
references: Proc Natl Acad Sci U S A. 1987 Dec;84(24):8758-62
references: 2447583
references: Ann Neurol. 1991 Nov;30(5):717-23
references: 1662477
references: Biochemistry. 2005 Apr 19;44(15):5835-41
references: 15823042
references: Bioorg Med Chem Lett. 1998 Apr 21;8(8):971-6
references: 9871522
references: Biochemistry. 2007 Feb 20;46(7):2027-36
references: 17256974
references: Science. 1994 Nov 11;266(5187):1059-62
references: 7973663
references: Biochem J. 1991 Jan 1;273(Pt 1):165-71
references: 1671202
references: Neuropathology. 2010 Apr;30(2):182-8
references: 20102521
references: Proc Natl Acad Sci U S A. 1994 Sep 13;91(19):8752-6
references: 8090718
references: Neuropharmacology. 1996;35(12):1689-702
references: 9076748
references: Pharmacol Rev. 1999 Mar;51(1):7-61
references: 10049997
references: Epilepsia. 2003 Jan;44(1):46-53
references: 12581229
references: Mol Pharmacol. 1994 Jul;46(1):129-38
references: 8058047
references: Neuroreport. 2004 Nov 15;15(16):2477-80
references: 15538178
references: J Med Chem. 1999 Oct 21;42(21):4414-21
references: 10543885
references: Nature. 2000 Feb 10;403(6770):614-5
references: 10688187
references: Brain Res Bull. 2006 Jul 31;70(3):260-2
references: 16861112
references: J Neurosci Res. 2006 Jan;83(1):134-46
references: 16323214
references: Proc Natl Acad Sci U S A. 1993 Jul 15;90(14):6591-5
references: 8393571
references: Curr Top Med Chem. 2011;11(7):810-8
references: 21291395
references: Neurology. 2002 Jun 11;58(11):1680-2
references: 12058100
references: J Neurosci. 2000 Mar 15;20(6):2166-74
references: 10704491
references: J Biol Chem. 2004 Feb 6;279(6):3990-7
references: 14610080
references: Neurosci Lett. 2003 Jun 5;343(2):81-4
references: 12759169
references: Neuroreport. 1993 Oct 25;5(1):93-4
references: 7506593
references: Neurochem Int. 2008 Jan;52(1-2):166-83
references: 17707550
references: Mol Cell Biol. 1987 Aug;7(8):2745-52
references: 3670292
references: J Biol Chem. 1981 Oct 10;256(19):10084-7
references: 6115859
references: Neurology. 2006 Jul 11;67(1):20-7
references: 16832072
references: Biochemistry. 2008 Jan 22;47(3):1061-9
references: 18161947
references: Neuropharmacology. 1996;35(12):1681-8
references: 9076747
references: Pharmacol Rev. 2010 Sep;62(3):405-96
references: 20716669
references: Biochemistry. 2011 Aug 23;50(33):7284-93
references: 21751782
references: Science. 1990 Sep 28;249(4976):1580-5
references: 1699275
references: Cancer. 2010 Apr 1;116(7):1776-82
references: 20143438
references: Epilepsy Res. 1999 Sep;36(2-3):189-204
references: 10515165
references: Curr Pharm Des. 2002;8(10):913-39
references: 11945139
references: Biochemistry. 2003 Oct 28;42(42):12358-66
references: 14567697
references: Amyotroph Lateral Scler Other Motor Neuron Disord. 2005 Sep;6(3):131-44
references: 16183555
references: J Neurosci Methods. 2005 Mar 15;142(1):159-66
references: 15652630
references: Neurosci Lett. 2000 Jun 23;287(2):161-5
references: 10854736